Copeland Capital Management, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 17 filers reported holding Novozymes A/S in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Copeland Capital Management, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2020$2,0000.0%350.0%0.00%
Q3 2020$2,0000.0%350.0%0.00%
Q2 2020$2,0000.0%350.0%0.00%
Q1 2020$2,0000.0%350.0%0.00%
Q4 2019$2,000
+100.0%
350.0%0.00%
Q3 2019$1,000
-50.0%
350.0%0.00%
Q2 2019$2,000350.00%
Other shareholders
Novozymes A/S shareholders Q2 2019
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders